Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1 (5-Year IF – 2.0)
Journal Citation Indicator (JCI) (2023) – 0.4
Scopus CiteScore – 3.7 (CiteScore Tracker – 4.0)
Index Copernicus  – 171.00; MNiSW – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (PL)

Advances in Clinical and Experimental Medicine

2006, vol. 15, nr 4, July-August, p. 689–694

Publication type: review article

Language: Polish

Czynniki wpływające na długość przeżycia chorych w programie dializ

Factors Influencing Survival of Patients on Regular Dialysis Treatment

Alicja E. Grzegorzewska1,

1 Katedra i Klinika Nefrologii, Transplantologii i Chorób Wewnętrznych AM w Poznaniu

Streszczenie

W pracy poglądowej przedstawiono czynniki wpływające na przeżycie chorych dializowanych, uwzględniając choroby współistniejące, wiek i płeć chorych, infekcyjne i nieinfekcyjne stany zapalne, stan odżywienia, adekwatność dializy, stężenie hemoglobiny, opiekę przeddializacyjną i czasokres dializowania. Podkreślono, że w praktyce klinicznej o przeżyciu chorych decyduje najczęściej niekorzystne współdziałanie kilku czynników.

Abstract

This review article presents factors influencing survival of dialysis patients, putting a special attention for comorbidity, age and gender of patients, infectious and non−infectious inflammatory status, nutritional parameters, dialysis adequacy, hemoglobin concentration, predialysis care and dialysis duration. It is pointed out that in clinical practice usually coincidence of several deteriorating factors predicts dialysis outcome.

Słowa kluczowe

choroby współistniejące, wiek, stan zapalny, opieka przeddializacyjna

Key words

comorbidity, age, inflammation, predialysis care

References (39)

  1. Rayner HC, Pisoni RL, Bommer J, Canaud B, Hecking E, Locatelli F, Piera L, Bragg−Gresham JL, Feldman HI, Goodkin DA, Gillespie B, Wolfe RA, Held PJ, Port FK: Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2004, 19, 108–120.
  2. Hsu SP, Pai MF, Peng YS, Chiang CK, Ho TI, Hung KY: Serum uric acid levels show a „J−shaped” association with all cause mortality in haemodialysis patients. Nephrol Dial Transplant 2004, 19, 457–462.
  3. Kalantar−Zadeh K, Kopple JD, Humphreys MH, Block G: Comparing outcome predictability of markers of malnutrition–inflammation complex syndrome in haemodialysis patients. Nephrol Dial Transplant 2004, 19, 1507–1519.
  4. Chung SH, Chu WS, Lee HA, Kim YH, Lee IS, Lindholm B, Lee HB: Peritoneal transport characteristics, comorbid diseases and survival in CAPD patients. Perit Dial Int 2000, 20, 541–547.
  5. Szeto OC, Yuk−Hwa Wong T, Chow KM, Leung CB, Law MC, Kam−Tao Li P: Independent effects of renal and peritoneal clearances on the mortality of peritoneal dialysis patients. Perit Dial Int 2004, 24, 58–64.
  6. US Renal Data System. 1999 Annual Data Report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, April 1999.
  7. Block GA, Hulbert−Shearon TE, Levin NW, Port FK: Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998, 31, 607–617.
  8. Musi B, Braide M, Carlsson O, Wieslander A, Albrektsson A, Ketteler M, Westenfeld R, Floege J, Rippe B: Biocompatibility of peritoneal dialysis fluids: Long−term exposure of nonuremic rats. Perit Dial Int 2004, 24, 37–47.
  9. Shoji T, Fukumoto M, Kimoto E, Shinohara K, Emoto M, Tahara H, Koyama H, Ishimura E, Nakatani T, Miki T, Tsujimoto Y, Tabata T, Nishizawa Y: Antibody to oxidized low−density lipoprotein and cardiovascular mortality in end−stage renal disease. Kidney Int 2002, 62, 2230–2237.
  10. Nakamoto H, Suzuki H for the Japan PDC Study Group: Hypoproteinemia in patients with diabetes undergoing continuous ambulatory peritoneal dialysis is attributable to high permeability of peritoneal membrane. Perit Dial Int 2003, 23, suppl. 2, S72–S78.
  11. Grzegorzewska AE, Dobrucka A, Mariak I: Nutrition and peritoneal dialysis adequacy in respect to age of patients. Ann Acad Med Ged 2003, 33, suppl. 1, 141–148.
  12. Grzegorzewska AE, Leander M: Total and subset lymphocyte count, angiotensin converting enzyme inhibitors and dialysis duration in younger and older peritoneal dialysis patients. Adv Perit Dial 2004, 20, 194–197.
  13. Ates K, Ertürk S, Nergisoglu G, Karatan O, Duman N, Erbay B, Ertug AE: Sex−dependent variations in peritoneal membrane transport properties in CAPD patients. Nephrol Dial Transplant 1996, 11, 2375–2376.
  14. Margetts PJ, McMullin JP, Rabbat CG, Churchill DN: Peritoneal membrane transport and hipoalbuminemia: cause or effect? Perit Dial Int 2000, 20, 14–18.
  15. Sonne−Holm S, Sorensen TI, Jensen G, Schnohr P: Independent effects of weight change and attained body weight on prevalence of arterial hypertension in obese and non−obese men. Br Med J 1989, 299, 767–770.
  16. Johnson DW, Herzig KA, Purdie DM, Chang W, Brown AM, Rigby RJ, Campbell SB, Nicol DL, Hawley CH: Is obesity a favorable prognostic factor in peritoneal dialysis patients? Perit Dial Int 2000, 20, 715–721.
  17. Canada – USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 1996, 7, 198–207.
  18. Rocco M, Soucie JM, Pastan S, McClellan WM: Peritoneal dialysis adequacy and risk of death. Kidney Int 2000, 58, 446–457.
  19. Bargman JM, Thorpe KE, Churchill DN: Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 2001, 12, 2158–2162.
  20. Szeto CC, Wong TY, Leung CB, Wang AY, Law MC, Lui SF, Li PK: Importance of dialysis adequacy in mortality and morbidity of Chinese CAPD patients. Kidney Int 2000, 58, 400–407.
  21. Paniagua R, Amato D, Vonesh E, Correa−Rotter R, Ramos A, Moran J, Mujais S; Mexican Nephrology Collaborative Study Group: Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002, 3, 1307–1320.
  22. Heimbürger O: The negative results of the ADEMEX study may be positive for peritoneal dialysis. Time for a paradigm shift in the focus of peritoneal dialysis adequacy? Perit Dial Int 2002, 22, 546–548.
  23. Bhaskaran S, Schaubel DE, Jassal SV, Thodis E, Singhal MK, Bargman JM, Vas SI, Oreopoulos DG: The effect of small solute clearances on survival of anuric peritoneal dialysis patients. Perit Dial Int 2000, 20, 181–187.
  24. Szeto CC, Wong TY, Chow KM, Leung CB, Law MC, Wang AY, Lui SF, Li PK: The impact of dialysis adequacy on the mortality of anuric Chinese patients receiving continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 2001, 12, 355–360.
  25. Port FK, Wolfe RA, Hulbert−Shearon TE, Daugirdas JT, Agodoa LY, Jones C, Orzol SM, Held PJ: Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the USRDS Dialysis Morbidity and Mortality Study. Am J Kidney Dis 2001, 37, 276–286.
  26. Port FK, Rasmussen CS, Leavy SF: Association of blood flow rate (BFR) and treatment time (TT) with mortality risk (RR) in haemodialysis patients across three continents. Abstr J Am Soc Nephrol 2001, 12, 343A–344A.
  27. Hornberger JC, Chernew M, Petersen J, Garber AM: A multivariate analysis of mortality and hospital admissions with high−flux dialysis. J Am Soc Nephrol 1992, 3, 1227–1237.
  28. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R; Hemodialysis (HEMO) Study Group: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Eng J Med 2002, 347, 2010–2019.
  29. Locatelli F, Pisoni RL, Combe C, Bommer J, Andreucci VE, Piera L, Greenwood R, Feldman HI, Port FK, Held PJ: Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2004, 19, 121–132.
  30. Jungers P: Late referral: loss of chance for the patient, loss of money for society. Nephrol Dial Transplant 2002, 17, 371–375.
  31. Roubicek C, Brunet P, Huiart L, Thirion X, Leonetti F, Dussol B, Jaber K, Andrieu D, Ramananarivo P, Berland Y: Timing of nephrology referral: influence on mortality and morbidity. Am J Kidney Dis 2000, 36, 35–41.
  32. Sesso R, Belasco AG: Late diagnosis of chronic renal failure and mortality on maintenance dialysis. Nephrol Dial Transplant 1996, 11, 2417–2420.
  33. Campbell JD, Ewigman B, Hosokawa M, van Stone JC: The timing of referral of patients with end−stage renal disease. Nephrol Dial Transplant 1989, 18, 660–686.
  34. Winklemayer W, Owen W, Levin R, Avora J: A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol 2003, 14, 486–492.
  35. Kazmi WH, Obrador GT, Khan SS, Pereira BJG, Kausz AT: Late nephrology referral and mortality among patients with end−stage renal disease: a propensity score analysis. Nephrol Dial Transplant 2004, 19, 1808–1814.
  36. Passlick−Deetjen J, Chlebowski H, Koch M, Grabensee B: Changes of peritoneal membrane function during long−term CAPD. Adv Perit Dial 1990, 6, 35–43.
  37. Yoshino A, Honda M, Fukuda M, Araki Y, Hataya H, Sakazume S, Tanaka Y, Kawamura K, Murai T, Kamiyama Y: Changes in peritoneal equilibration test values during long−term peritoneal dialysis in peritonitis free children. Perit Dial Int 2001, 21, 180–185.
  38. Marcën R, Teruel JL, Angel de la Cal M, Gamez C and the Spanish Cooperative Study of Nutrition in Hemodialysis: The impact of malnutrition in morbidity and mortality in stable haemodialysis patients. Nephrol Dial Transplant 1997, 12, 2324–2331.
  39. Chazot Ch, Blanc C, VoVan C, Jean G, Vanel T, Terrat JC, Ruffet M: Malnutrition in long−term haemodialysis survivors. Nephrol Dial Transplant 2001, 16, 61–69.
© Wroclaw Medical University